:: SIHL ::

Company Profile

Smart Quotes

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE8740.45-124.65 (-1.41 %)

PREV CLOSE ( ) 8865.10

OPEN PRICE ( ) 8865.10

BID PRICE (QTY) 8731.20 (5)

OFFER PRICE (QTY) 8739.60 (2)

VOLUME 547

TODAY'S LOW / HIGH ( )8728.55 8866.45

52 WK LOW / HIGH ( )6160.25 10653.05

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-07 1979

Management Info

Shilpa Divekar Nirula - Chairman Sanjeev Kumar Panchal - Managing Director

Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone 080 6774 8000

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com/india

Registrar's Details

Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)

30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore

Listing : BSE, NSE

NEWS

30May AstraZeneca Pharma gets permission to
AstraZeneca Pharma India has received permission from the Central Drugs..

30May AstraZeneca Pharma soars on getting pe
Astrazeneca Pharma India is currently trading at Rs. 8026.05, up by 107...

30May AstraZeneca Pharma India informs abou
AstraZeneca Pharma India has informed that the company has received perm..

29May Astrazeneca Pharma India receives appr
Astrazeneca Pharma India has received permission from the Central Drugs..

15Apr AstraZeneca Pharma India informs about
AstraZeneca Pharma India has informed that AstraZeneca Pharma India had..

Financials

in Crores

	QTR Mar 25	ANNUAL 25
Net Profit	58.25	115.74
Gross Profit	78.47	156.36
Operating Profit	102.52	294.6
Net Sales	480.48	1716.29

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 32846.90 (3.64%)	M.Cap ( in Cr)70065.43
Sanofi India (BSE) 6181.25 (1.83%)	M.Cap ( in Cr)14235.80
Pfizer (BSE) 5651.00 (1.32%)	M.Cap ( in Cr)25810.18
TTK Healthcare (BSE) 1299.35 (3.10%)	M.Cap ( in Cr)1836.02
Glaxosmithkline Phar (BSE) 3288.80 (0.80%)	M.Cap ( in Cr)55819.29

Shareholding Pattern

	PROMOTERS	75%
	NON-INSTITUTION	17.48%
	MUTUAL FUNDS/UTI	4.45%
	FI/BANKS/INSURANCE	0.16%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bandhan Innovation Fund-Reg(G)	4.04
Baroda BNP Paribas Manufacturing Fund-Reg(G)	2.40
DSP Nifty Smallcap250 Quality 50 Index Fund-Reg(G)	1.84
Bandhan Aggressive Hybrid Fund-Reg(G)	1.61
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)	1.05
Nippon India Small Cap Fund(G)	1.02
ICICI Pru Smallcap Fund(G)	1.02

SIHL House, Opp.Ambawadi Jain Temple, Nehrunagar Cross Roads, Ahmedabad-380015

Prevent Unauthorised transactions in your account. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge as well as for mobile no and for email id updation.Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors".

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account

REGISTRATION NO

SEBI Regn.no. INZ000167335 Member Code: NSE-07590 BSE Sebi Regn. 943 AMFI ARN- 39843 SEBI Registration No. (DP)- IN-DP-465-2020 NSDL:IN-DP-NSDL-34-97,DP ID:IN300343 CDSL:IN-DP-CSDL-199-2003,DP ID:12029300 Approved person Registration no. with NSDL Database Management Limited(NDML) :IRDA/IR1/2013/004Approved person Registration no. with Center Insurance Repository Limited (CIR): IRDA/IR2/2013/123

REGISTERED ADDRESS:

810, X-Change Plaza, DSCCSL (53E), Road 5E, Block 53, Zone 5, Gift City, Gandhinagar 382050

SHAH INVESTOR'S HOME LTD. CIN NO:-U67120GJ1994PLC023257 SIHL COMMODITIES LTD. CIN NO:-U45201GJ1995PLC025825SIHL CONSULTANCY LTD. CIN NO:-U74140GJ2006PLC049662 SIHL FINCAP LTD.CIN NO:-U65923GJ2006PLC049661 SIHL GLOBAL INVESTMENTS (IFSC) PVT. LTD. CIN NO:-U67190GJ2016PTC094444NSEL MemberCode :10560

CORRESPONDENCE ADDRESS:

SIHL House, Opp. Ambawadi Jain Temple, Nehrunagar Cross Road, Ahmedabad-380015.

For any complains email us at investors@sihl.in Shah Investor's Home Ltd. Member: